Emergent BioSolutions Inc.
EBS- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001367644
In the last 90 days, Emergent BioSolutions Inc. insiders filed 0 open-market purchases and 1 sale; 194 institutions reported holding it in 13F filings for Q2 2026, worth $373.6M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Emergent BioSolutions Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 134 | 121 | −13 |
| Shares | 40.9M | 36.0M | −4.95M (−12.1%) |
| Value | $98.2M | $90.8M | −$7.35M (−7.5%) |
New holders (20)
Institutions that held Emergent BioSolutions Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Avidity Partners Management LP | 1,908,000 | $4.83M | 0.17% |
| Fuller & Thaler Asset Management, Inc. | 775,625 | $1.96M | 0.01% |
| Cetera Investment Advisers | 170,951 | $432.5K | 0.00% |
| Aristeia Capital LLC | 144,788 | $366.3K | 0.02% |
| Susquehanna Fundamental Investments, LLC | 118,647 | $300.2K | 0.01% |
| SeaCrest Wealth Management, LLC | 96,000 | $242.9K | 0.03% |
| Fidelis Capital Partners, LLC | 24,017 | $60.8K | 0.01% |
| XTX Topco Ltd | 19,736 | $49.9K | 0.01% |
| Eqis Capital Management, Inc. | 15,811 | $40.0K | 0.00% |
| Creative Planning | 14,048 | $35.5K | 0.00% |
| Toroso Investments, LLC | 13,352 | $33.8K | 0.00% |
| Avidian Wealth Solutions, LLC | 13,235 | $33.5K | 0.00% |
| Envestnet Asset Management Inc | 13,153 | $33.3K | 0.00% |
| Manufacturers Life Insurance Company, The | 11,604 | $29.4K | 0.00% |
| StoneX Group Inc. | 10,367 | $26.2K | 0.00% |
| Capital Advisors, Ltd. LLC | 2,002 | $5.00K | 0.00% |
| Register Financial Advisors LLC | 200 | $506 | 0.00% |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 10 | $25 | 0.00% |
| Frazier Financial Advisors, LLC | 2 | $6 | 0.00% |
| Mirae Asset Global Investments Co., Ltd. | 22,389 | – | – |
Sold out (33)
Institutions that held Emergent BioSolutions Inc. at the end of Q4 2023 and filed for Q1 2024 without it.